Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (115966)
Text and Data Mining valid from 2019-06-21
First Online: 21 June 2019
Compliance with Ethical Standards
: This study is part of the PREFER project. PREFER is a 5-year project that has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant agreement no. 115966. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations. The funding source did not have a role in the study design, collection, analysis, and interpretation of the data, in the writing of the article, and in the decision to submit it for publication.
: Jürgen Kübler’s work was funded by CSL Behring. Bennett Levitan is an employee of Janssen Research and Development, LLC. He is a stockholder in Johnson & Johnson, Baxter International, Inc., Pharmaceutical Holders Trust, and Zimmer Holdings, Inc. He also owns stock in a variety of companies that at times include other pharmaceutical and healthcare-related companies. Richard Hermann is an employee and stockholder at AstraZeneca Pharmaceuticals, LP. Juhaeri Juhaeri is an employee of Sanofi and a holder of stock options and restricted shares of Sanofi. He also owns accounts in various investment companies that may include other biopharmaceutical and healthcare-related companies. Sarah Harding is an employee of Takeda International, UK Branch.
: Ethics approval was obtained in all countries where interviewees were recruited (registration number, country): Medical Ethics Committee of UZ KU Leuven/Research (S59790, Belgium), Commission Nationale de l’Informatique et des Libertés (2036344, CNIL, France), Ethik-Kommission der Friedrich-Alexander Universität (92_17 B, Germany), Comitato Etico Instituto Europeo di Oncologia (R587/17-IEO 609, Italy), Medisch Ethische Toetsings Commissie Erasmus Medical Centre (WT/ss/METC306661, the Netherlands), Comisia de Bioetica a Medicamentului si a Dispozitivelor Medicale [CNBMDM] (5 SNI, Romania), Regionala Etikprövningsnämnden Uppsala (EPN] (2017/001/1, Sweden), Newcastle University Ethics Committee (11307/2016, UK), and Western Institutional Review Board [WIRB] (1-1010535-1, USA).
: All interviewees provided written informed consent to participate in the interview and for using the coded data of their interview for publication in scientific journals.
: The data are not publicly available because they contain information that could compromise interviewees’ privacy and consent.